Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?
McFadden
E R
ER
D000208:Acute Disease; D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005541:Forced Expiratory Volume / Q000187:drug effects; D005802:Genes, MHC Class II / Q000187:drug effects; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D010366:Peak Expiratory Flow Rate / Q000187:drug effects; D011965:Receptors, Glucocorticoid / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D011965:Receptors, Glucocorticoid; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide; D000420:Albuterol